|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM076787788 |
003 |
DE-627 |
005 |
20250129121232.0 |
007 |
tu |
008 |
231222s1995 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed25n0256.xml
|
035 |
|
|
|a (DE-627)NLM076787788
|
035 |
|
|
|a (NLM)7702842
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Meador, J W
|c 3rd
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a pTRIPLEscript
|b a novel cloning vector for generating in vitro transcripts from tandem promoters for SP6, T7 and T3 RNA polymerase
|
264 |
|
1 |
|c 1995
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 10.05.1995
|
500 |
|
|
|a Date Revised 21.11.2008
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a We have constructed a family of novel in vitro transcription vectors in which functional T3, T7 and SP6 RNA polymerase promoters are arranged in tandem and directed towards a multiple cloning site. This prototype vector, named pTRIPLEscript, permits the transcription of one strand of a DNA insert by any of the three commonly used bacteriophage RNA polymerases with no apparent cross talk, i.e., use of the wrong promoter sequence. The vector has two main uses: (i) to clone probe sequences that will be distributed to many laboratories, allowing the use of the most convenient RNA polymerase; and (ii) to circumvent the problem of RNA polymerase-dependent premature termination
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Viral Proteins
|2 NLM
|
650 |
|
7 |
|a RNA polymerase SP6
|2 NLM
|
650 |
|
7 |
|a EC 2.7.7.-
|2 NLM
|
650 |
|
7 |
|a bacteriophage T3 RNA polymerase
|2 NLM
|
650 |
|
7 |
|a EC 2.7.7.-
|2 NLM
|
650 |
|
7 |
|a bacteriophage T7 RNA polymerase
|2 NLM
|
650 |
|
7 |
|a EC 2.7.7.-
|2 NLM
|
650 |
|
7 |
|a DNA-Directed RNA Polymerases
|2 NLM
|
650 |
|
7 |
|a EC 2.7.7.6
|2 NLM
|
700 |
1 |
|
|a McElroy, H E
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Pasloske, B L
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Milburn, S C
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Winkler, M M
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t BioTechniques
|d 1988
|g 18(1995), 1 vom: 01. Jan., Seite 152-7,
|w (DE-627)NLM012627046
|x 0736-6205
|7 nnns
|
773 |
1 |
8 |
|g volume:18
|g year:1995
|g number:1
|g day:01
|g month:01
|g pages:152-7,
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_21
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_39
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_50
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_62
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_99
|
912 |
|
|
|a GBV_ILN_121
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_227
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_618
|
912 |
|
|
|a GBV_ILN_640
|
912 |
|
|
|a GBV_ILN_754
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a GBV_ILN_2002
|
912 |
|
|
|a GBV_ILN_2003
|
912 |
|
|
|a GBV_ILN_2005
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a GBV_ILN_2007
|
912 |
|
|
|a GBV_ILN_2008
|
912 |
|
|
|a GBV_ILN_2009
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a GBV_ILN_2012
|
912 |
|
|
|a GBV_ILN_2015
|
912 |
|
|
|a GBV_ILN_2018
|
912 |
|
|
|a GBV_ILN_2023
|
912 |
|
|
|a GBV_ILN_2035
|
912 |
|
|
|a GBV_ILN_2040
|
912 |
|
|
|a GBV_ILN_2060
|
912 |
|
|
|a GBV_ILN_2099
|
912 |
|
|
|a GBV_ILN_2105
|
912 |
|
|
|a GBV_ILN_2121
|
912 |
|
|
|a GBV_ILN_2470
|
951 |
|
|
|a AR
|
952 |
|
|
|d 18
|j 1995
|e 1
|b 01
|c 01
|h 152-7,
|